Agilent Technologies Expands Catalog of SureFISH Probes to Largest Offering on the Market

Agilent Technologies Inc. (NYSE: A) today launched additional Agilent SureFISH probes, creating the largest offering of oligonucleotide-based fluorescent in situ hybridization (FISH) assays on the market. Over 425 probes are now available from Agilent, including centromere probes for all 24 chromosomes, and 35 telomere probes. Agilent SureFISH probes are designed for specific, nonrepetitive regions of [...]

Trovagene, Inc. Announces Pricing of Public Offering of 1,150,000 Units, Listing on NASDAQ and Effectiveness of Reverse Stock Split

SAN DIEGO, -- Trovagene, Inc. (Nasdaq: TROVD), a developer of trans-renal molecular diagnostics, announced the pricing of an underwritten public offering of 1,150,000 units at an offering price of $8.00 per unit, with each unit consisting of two shares of common stock and one warrant to purchase one share of common stock. The units will [...]

RURO Introduces New Version of Electronic Laboratory Notebook. Sciency ELN 3.5

RURO, Inc., a developer of research software and inventory solutions introduces a more robust lab notes system in Sciency 3.5. Here are the new Sciency ELN upgrades: • A “discussion" section has been added to every project. This is a place users can leave feedback and ask questions. • Sciency ELN can now be linked [...]

Recently Published Independent Research Study Detects Gene Variation In Non-Small Cell Lung Cancer Using The Sequenom Massarray® Research Use System

SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported on a recently released publication in which the Sequenom MassARRAY® System (for research use only) was used in a groundbreaking independent study that detected the transforming fusion gene EML4/ALK in non-small cell lung cancer. The study was [...]

Smiths Detection unveils High Speed Checked Baggage Scanner

London, UK,- Smiths Detection today gave the first public preview of a next-generation, high-speed scanner for screening checked airport baggage for explosives. The new scanner was developed in cooperation with Analogic Corporation. Images and details of the newly named HI-SCAN 10080 XCT, currently being tested by international regulatory agencies, were revealed at an Investor Day [...]

SCIENION introduces a new version of sciFLEXARRAYER S1 for non-contact piezo dispensing

Scienion launches the new version of its sciFLEXARRAYER S1 at European Lab Automation in Hamburg, May 30-31. The small compact non-contact piezo dispensing roboter with an increased throughput and versatility offers precise ultra-low volume liquid handling for a variety of applications in multiplexed diagnostics and cellular screening approaches. Dortmund and Berlin, Germany, May 25, 2012: [...]

Implanted Body Bombs can be Detected, says Smiths Detection

London, UK, - Explosives surgically implanted or inserted in body cavities by terrorists intent on destroying planes in mid-air can be detected by technology already used to combat contraband threats, the President of Smiths Detection said today. Speaking at an investor event in London, Mal Maginnis said the apparently growing threat from such tactics could [...]

New Research Center to Focus on Mammalian Single Cell Genomics

The Broad Institute and Fluidigm Corporation have announced the launch of a new research center dedicated to accelerating the development of research methods and discoveries in mammalian single-cell genomics. The Single-Cell Genomics Center is also expected to act as a hub for collaboration among single-cell genomics researchers in many pioneering fields, including stem cells and [...]

Company Recognized for Outstanding Contributions to the Pharmaceutical Sciences

Exton, PA, -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, “Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase [...]

NanoString Technologies Names Bruce Seeley Senior Vice President & General Manager, Diagnostics

SEATTLE, Wash. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of Bruce J. Seeley as Senior Vice President & General Manager, Diagnostics. In this role, Mr. Seeley will have responsibility for providing strategic direction and commercial leadership for NanoString’s [...]

Access IBO on Knowledge Center